Researchers in Taiwan tested BPC-157, the same gastric-derived peptide studied for gut and nerve injuries, directly on tendon tissue and tendon cells from rat Achilles tendons growing in a lab dish, to see what the peptide was actually doing to the cells themselves.
In the peer-reviewed study, tendon fibroblasts exposed to BPC-157 grew out of tendon tissue explants faster, migrated more readily across a lab dish, and survived better under stress than untreated cells. The peptide appeared to work through the FAK-paxillin signaling pathway, a route cells use to sense and move across a surface.
The cell-level result matters because it points to a specific mechanism, not just an outcome, behind the faster tendon healing earlier reported in rats. Most published work on BPC-157 and tendons comes from two groups, in Zagreb and in Taiwan, and no outside laboratory has independently repeated the cell migration findings, so the mechanism remains a single-lab observation.

Read the original study
Chang et al., Journal of Applied Physiology, 2011 · doi.org/10.1152/japplphysiol.00945.2010
One lab's cells, moving faster.
Source
- Chang, C.-H., Tsai, W.-C., Lin, M.-S., Hsu, Y.-H., & Pang, J.-H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology (Bethesda, Md., 110(3), 774–80. https://doi.org/10.1152/japplphysiol.00945.2010